What is CEL-SCI Corp?
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 21.28M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 1100,000 shares $138k |
| 3-6months | 0 | 0 |
| 6-9months | 0 | 2400,000 shares $479k |
| 9-12months | 0 | 246,412 shares $250k |